Skip to content
10-Q

Quarterly Report

Cyteir Therapeutics, Inc.

0000950170-23-059370

← back to feed
Filed
Nov 6, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q3 2023 · Sep 30, 2023 36.03M sh
Shares Diluted Q3 2023 · Sep 30, 2023 35.65M sh
Shares Diluted Q3 2023 · Sep 30, 2022 35.33M sh
Shares Diluted Q3 2023 · Sep 30, 2022 35.28M sh
Operating Cash Flow Q3 2023 · Sep 30, 2023 −$18.87M
Operating Cash Flow Q3 2023 · Sep 30, 2022 −$35.62M
Cash And Equivalents Q3 2023 · Sep 30, 2023 $129.24M
Cash And Equivalents Q3 2023 · Dec 31, 2022 $147.12M
Cash And Equivalents Q3 2023 · Sep 30, 2022 $153.89M
Stockholders Equity Q3 2023 · Sep 30, 2023 $125.03M
Stockholders Equity Q3 2023 · Jun 30, 2023 $127.79M
Stockholders Equity Q3 2023 · Mar 31, 2023 $134.98M
Stockholders Equity Q3 2023 · Dec 31, 2022 $146.29M
Stockholders Equity Q3 2023 · Sep 30, 2022 $154.03M
Stockholders Equity Q3 2023 · Jun 30, 2022 $163.78M
Stockholders Equity Q3 2023 · Mar 31, 2022 $174.5M
Stockholders Equity Q3 2023 · Dec 31, 2021 $187.29M
Current Liabilities Q3 2023 · Sep 30, 2023 $5.97M
Current Liabilities Q3 2023 · Dec 31, 2022 $5.32M
Total Liabilities Q3 2023 · Sep 30, 2023 $5.98M
Total Liabilities Q3 2023 · Dec 31, 2022 $6.95M
Current Assets Q3 2023 · Sep 30, 2023 $130.64M
Current Assets Q3 2023 · Dec 31, 2022 $149.21M
Total Assets Q3 2023 · Sep 30, 2023 $131.01M
Total Assets Q3 2023 · Dec 31, 2022 $153.23M
Eps Diluted Q3 2023 · Sep 30, 2023 −$0.10
Eps Diluted Q3 2023 · Sep 30, 2023 −$0.68
Eps Diluted Q3 2023 · Sep 30, 2022 −$0.31
Eps Diluted Q3 2023 · Sep 30, 2022 −$1.06
Eps Basic Q3 2023 · Sep 30, 2023 −$0.10
Eps Basic Q3 2023 · Sep 30, 2023 −$0.68
Eps Basic Q3 2023 · Sep 30, 2022 −$0.31
Eps Basic Q3 2023 · Sep 30, 2022 −$1.06
Sga Expense Q3 2023 · Sep 30, 2023 $2.5M
Sga Expense Q3 2023 · Sep 30, 2023 $10.81M
Sga Expense Q3 2023 · Sep 30, 2022 $3.49M
Sga Expense Q3 2023 · Sep 30, 2022 $10.96M
Rd Expense Q3 2023 · Sep 30, 2023 $2.68M
Rd Expense Q3 2023 · Sep 30, 2023 $17.39M
Rd Expense Q3 2023 · Sep 30, 2022 $8.27M
Rd Expense Q3 2023 · Sep 30, 2022 $27.15M
Net Income Q3 2023 · Sep 30, 2023 −$3.53M
Net Income Q3 2023 · Sep 30, 2023 −$24.42M
Net Income Q3 2023 · Jun 30, 2023 −$8.4M
Net Income Q3 2023 · Mar 31, 2023 −$12.49M
Net Income Q3 2023 · Sep 30, 2022 −$11.05M
Net Income Q3 2023 · Sep 30, 2022 −$37.27M
Net Income Q3 2023 · Jun 30, 2022 −$12.12M
Net Income Q3 2023 · Mar 31, 2022 −$14.1M
Operating Income Q3 2023 · Sep 30, 2023 −$5.17M
Operating Income Q3 2023 · Sep 30, 2023 −$28.2M
Operating Income Q3 2023 · Sep 30, 2022 −$11.76M
Operating Income Q3 2023 · Sep 30, 2022 −$38.12M
Capex Q3 2023 · Sep 30, 2022 $312K